- Home
- VNDA vs NEN Comparison
VNDA vs NEN Comparison
Compare VNDA & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- NEN
- Stock Information
- Founded
- VNDA 2002
- NEN 1977
- Country
- VNDA United States
- NEN United States
- Employees
- VNDA N/A
- NEN N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- NEN Building operators
- Sector
- VNDA Health Care
- NEN Real Estate
- Exchange
- VNDA Nasdaq
- NEN Nasdaq
- Market Cap
- VNDA 270.0M
- NEN 282.1M
- IPO Year
- VNDA 2006
- NEN N/A
- Fundamental
- Price
- VNDA $4.77
- NEN $80.19
- Analyst Decision
- VNDA Strong Buy
- NEN
- Analyst Count
- VNDA 2
- NEN 0
- Target Price
- VNDA $15.50
- NEN N/A
- AVG Volume (30 Days)
- VNDA 704.2K
- NEN 121.0
- Earning Date
- VNDA 02-05-2025
- NEN 01-01-0001
- Dividend Yield
- VNDA N/A
- NEN 1.99%
- EPS Growth
- VNDA N/A
- NEN 67.91
- EPS
- VNDA N/A
- NEN 3.91
- Revenue
- VNDA $190,858,000.00
- NEN $81,169,352.00
- Revenue This Year
- VNDA $5.60
- NEN N/A
- Revenue Next Year
- VNDA $42.85
- NEN N/A
- P/E Ratio
- VNDA N/A
- NEN $20.63
- Revenue Growth
- VNDA N/A
- NEN 10.81
- 52 Week Low
- VNDA $3.46
- NEN $67.04
- 52 Week High
- VNDA $6.75
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- VNDA 42.69
- NEN 38.67
- Support Level
- VNDA $4.49
- NEN $82.10
- Resistance Level
- VNDA $4.81
- NEN $82.74
- Average True Range (ATR)
- VNDA 0.18
- NEN 0.08
- MACD
- VNDA -0.03
- NEN -0.29
- Stochastic Oscillator
- VNDA 25.71
- NEN 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.